Infant Formula Sector: Growth Drivers and Challenges
Growth Drivers
-
Surge in the Total Number of Working Mothers is likely to Boost the Market Growth
-
Rising Cases of Diseases Which Prevent Mothers from Breastfeeding likely to Promote the Market Growth
Challenges
-
High Cost of Infant Formula Products is Anticipated to Restrain the Market Growth
Infant Formula Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.6% |
|
Base Year Market Size (2024) |
USD 50.74 billion |
|
Forecast Year Market Size (2037) |
USD 148.3 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of infant formula is estimated at USD 54.45 billion.
Infant Formula Market size was over USD 50.74 billion in 2024 and is poised to exceed USD 148.3 billion by 2037, witnessing over 8.6% CAGR during the forecast period i.e., between 2025-2037.
North America industry is set to account for largest revenue share by 2037, owing to presence of leading companies in the region.
The major players in the market are Nestle S.A., Pfizer Inc., Nature’s One, LLC, The LittleOak Company Pty Limited, Royal FrieslandCampina N.V., and others.
